Ovarian Cancer
-
When Cancer Is in the Family
You've inherited a genetic variant linked to cancer risk. Now what?
by Stephen Ornes
-
Genetic Testing Gaps
Testing for hereditary mutations is increasingly recommended for people with cancer, but recommendations do not always translate into access to testing and appropriate counseling.
by Kate Yandell
-
Survivor Profile
Sharing Her Strength
Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.
by Lindsey Konkel
-
Medicare Coverage for Next-Generation Sequencing Tests
Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.
by Ashley P. Taylor
-
BRCA: Who Should Be Tested?
Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out.
by Sue Rochman
-
Our Own Words
People with cancer and their loved ones find ways for their voices to be heard without filters.
by Bradley Jones
-
Finding Support in Unlikely Places
After her diagnosis with ovarian cancer, Patricia Anne Ward noticed that some friends and family pulled away. She found connection outside her usual circles.
by Patricia Anne Ward
-
Advocacy Spotlight: Sorting Out Priorities
Ovarian cancer survivor and research advocate Annie Ellis is teaming up with researchers to better equip patients with recurrent cancer to make treatment decisions.
by Cici Zhang
-
Forward Look
Little Consensus on Ovarian Cancer Monitoring
Tests and scans may be overused.
by Kate Yandell
-
Survivor Profile
Going Full Bore
Susan Leighton, a 19-year survivor, is a powerful advocate for ovarian cancer research. Her advocacy, which began locally in northern Alabama, has reached the National Cancer Institute and the Department of Defense.
by Sue Rochman
